Case Report

Effective Treatment of a Malignant Breast Phyllodes Tumor with Doxorubicin-Ifosfamide Therapy

Table 1

Doxorubicin-ifosfamide (AI) therapy regimen.

DrugVolume/doseInfusion timeTiming of administration

Days 1-2
Rp. 1Saline500 mL
SHC20 mL4 h
Rp. 2Saline100 mL
PH (day 1 only)0.75 mg
Dexamethasone9.9 mg15 min
Rp. 3Saline100 mL
Doxorubicin30 mg/m22 h
Rp. 4Saline50 mL
Mesna400 mL/m215 min
Rp. 5Saline500 mL
Ifosfamide2 g/m24 h
Rp. 6Saline500 mL
SHC20 mL4 h
Rp. 7Saline50 mL
Mesna400 mL/m215 min4 h after Rp. 5 administration
Rp. 8Saline500 mL
SHC20 mL4 h
Rp. 9Saline50 mL
Mesna400 mL/m215 min8 h after Rp. 5 administration
Days 3-5
Rp. 1Saline500 mL
SHC20 mL4 h
Rp. 2Saline100 mL
Dexamethasone9.9 mg15 min
Rp. 3Saline50 mL
Mesna400 mL/m215 min
Rp. 4Saline500 mL
Ifosfamide2 g/m24 h
Rp. 5Saline500 mL
SHC20 mL4 h
Rp. 6Saline50 mL
Mesna400 ml/m215 min4 h after Rp. 4 administration
Rp. 7Saline500 mL
SHC20 mL4 h
Rp. 8Saline50 mL
Mesna400 mL/m215 min8 h after Rp. 4 administration

Abbreviations: Rp: recipe; SHC: sodium hydrogen carbonate, 8.4%; PH: palonosetron hydrochloride; h: hour; min: minute; AI: doxorubicin-ifosfamide.